|
ALAS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.416400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.839200E-03 |
| Normal-vs-Stage2 |
4.371800E-01 |
| Normal-vs-Stage3 |
1.66160000003579E-06 |
| Normal-vs-Stage4 |
8.974900E-04 |
| Stage1-vs-Stage2 |
1.202590E-01 |
| Stage1-vs-Stage3 |
4.104000E-03 |
| Stage1-vs-Stage4 |
2.184200E-01 |
| Stage2-vs-Stage3 |
3.944100E-03 |
| Stage2-vs-Stage4 |
3.276500E-02 |
| Stage3-vs-Stage4 |
6.041600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.441800E-04 |
| Normal-vs-AfricanAmerican |
3.163600E-01 |
| Normal-vs-Asian |
1.026230E-01 |
| Caucasian-vs-AfricanAmerican |
3.248600E-01 |
| Caucasian-vs-Asian |
1.751430E-01 |
| AfricanAmerican-vs-Asian |
8.683800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.3486000000077E-05 |
| Normal-vs-Female |
3.238400E-03 |
| Male-vs-Female |
2.589000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.019900E-04 |
| Normal-vs-Age(41-60Yrs) |
7.957700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.871500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.294980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.605200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.683600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.041200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.169200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.479400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.629600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.078050E-02 |
| Classical-VS-Follicular |
1.024000E-03 |
| Classical-VS-Other |
2.013600E-01 |
| Classical-VS-Normal |
9.86010000000315E-05 |
| Tall-VS-Follicular |
3.27739999994581E-06 |
| Tall-VS-Other |
4.609000E-01 |
| Tall-VS-Normal |
3.53100000016759E-07 |
| Follicular-VS-Other |
2.661900E-03 |
| Follicular-VS-Normal |
7.237200E-01 |
| Other-VS-Normal |
4.699200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.191900E-02 |
| Normal-vs-N1 |
2.63469999994825E-06 |
| N0-vs-N1 |
2.998500E-03 |
|
|
